Snowball logo
logo
2079_logo

Samsung Biologics Co Ltd

207940 β€’ KO
β‚©1,564,000.00+β‚©15,000.00Β  (0.97%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
1,568,006.93,001,295.23,694,588.83,497,145.74,556,971.74,515,817.9
COGS
841,555.61,532,847.21,891,824.21,785,9612,040,331.32,052,103.5
Gross Profit
726,451.41,468,4481,802,764.61,711,184.72,516,640.42,463,714.5
Operating Expenses & Income
Operating Income
537,309.4983,627.41,113,6801,321,366.42,069,221.32,163,285.1
Total Operating Expenses
1,030,697.52,017,667.82,580,908.82,175,779.32,487,750.42,352,532.8
R&D Expenses
954.245,883.781,58836,710.837,181.2154,541.9
Selling General & Admin Expenses
103,009.5209,490.1303,534.5193,111.4169,633.3391,748.1
Earnings from Continuing Operations
Interest Expense
(14,707.2)(64,064.3)(81,596.4)(34,123.2)(29,171.3)(26,401.4)
Interest Income
9,655.953,292.695,650.154,404.346,033.746,775.8
Income Tax Expense
167,693.1210,968.4----
Net Income
Net Income
393,589.5798,056.2857,691.31,083,315.91,784,352.11,878,043.9
Supplemental
EBIT
537,309.4983,627.4----
EBITDA
737,778.41,381,353.2----
In millions of KRW, except % and values per 1 share